CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

May 3, 2022 · earnings

KYMR earnings: a negative outcome, -24.0%

On May 3, 2022, Kymera Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -24.0% in the window around the event. It had already run -24.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$32.73
1d before
$24.88
Event day
$22.04
1d after
$19.04
5d after

Pre-catalyst setup

-24.7%
30-day run-up
6612%
30-day volatility
1.5×
volume spike